Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BPBC
- Development stage
- Preclinical
- Lead developer
- Panacea Biotec
- Modality
- Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
- Administration
- Oral, Subcutaneous, Intramuscular, Intravenous, Intravesical, Topical
01
Overview
BPBC is a preclinical-stage, multi-epitope, nanoparticle-based vaccine candidate developed by Panacea Biotec in partnership with the Translational Health Science and Technology Institute (THSTI). Funded by the Coalition for Epidemic Preparedness Innovations (CEPI), the vaccine is designed to provide broad-spectrum protection against various betacoronaviruses, including SARS-CoV-2 variants, MERS-CoV, and SARS-CoV. The platform utilizes highly immunogenic antigens to elicit both humoral and cellular immune responses. The development program is currently in the antigen discovery and proof-of-concept phase, with the goal of creating a pan-betacoronavirus vaccine that can address future pandemic threats.
- Other names
- Panacea Biotec betacoronavirus vaccineTHSTI-Panacea betacoronavirus vaccine
Beyond the preview
Go deeper on BPBC.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BPBC.